# Taimei Technology and GreenLight Clinical Expand Strategic Partnership at AusBiotech 2026 to Pioneer AI-Native Trial Execution Across Asia-Pacific

- Link: https://www.thailand-business-news.com/pr-news/taimei-technology-and-greenlight-clinical-expand-strategic-partnership-at-ausbiotech-2026-to-pioneer-ai-native-trial-execution-across-asia-pacific
- Published: 2026-10-22T07:00:00+07:00
- Author: PR Newswire

GOLD COAST, Australia, Oct. 22, 2026 /PRNewswire/ — Taimei Technology, a global 
provider of AI-powered clinical development platforms, and GreenLight Clinical (
GLC), a physician-led contract research organization (CRO), today announced an expanded
strategic partnership at AusBiotech 2026. Evolving from a targeted software engagement
into an enterprise-wide alliance, the agreement equips GLC to scale trial delivery
across the Asia-Pacific (APAC) region using Taimei’s unified platform, protocol-
aware AI, and integrated clinical imaging solutions.

[⌊Signing Ceremony of Taimei Technology and GreenLight Clinical⌉⌊Signing Ceremony
of Taimei Technology and GreenLight Clinical⌉[
Signing Ceremony of Taimei Technology
and GreenLight Clinical

"Sponsors today require clinical partners who think like physicians but execute 
with modern technological velocity," said Dr. Robert Lin, CEO of GreenLight Clinical."
Having proven measurable gains with Taimei in data management and safety, expanding
across the wider trial lifecycle, imaging, and AI workflows was our natural next
step. Automating routine data workflows removes manual friction, allowing our medical
and operational teams to focus squarely on clinical excellence and accelerated study
delivery."

The expansion builds on a collaboration that began in 2024 with Taimei’s eCollect
EDC and later grew to encompass trial randomization (eBalance) and safety management(
eSafety). Under the expanded roadmap, the partners will scale usage across Taimei’s
unified platform, explore collaborative central imaging capabilities, embed intelligent
automation into routine workflows under clinical oversight, and, and over the long
term, building institutional memory into the platform to compound speed and quality
across future trials.

"GreenLight Clinical is setting a new standard for how modern CROs scale," said 
Zhao Lu, Chairman of Taimei Technology, whose expanded agreement was formalized 
onsite at AusBiotech by Vice President Ben Cai. When operational data and medical
oversight live on a single digital foundation, every completed study teaches the
system how to run the next one with greater precision. Partnering with GreenLight
Clinical brings that model to life—creating an adaptive clinical engine that continuously
reduces development timelines and brings life-changing therapies to patients sooner."

About Taimei Technology

Taimei Technology (02576.HK) is a leading global AI-powered clinical development
platform supporting pharmaceutical R&D, safety surveillance and commercialization.
Taimei serves 1,600+ biopharma organizations and CROs across 30+ countries and regions.

Website: [www.taimei.com](http://www.taimei.com/)

About GreenLight Clinical

GreenLight Clinical is a physician-led, solutions-focused contract research organization(
CRO) with operations across Australia and the broader Asia-Pacific region. Specializing
in Phase I to Phase III trials across oncology, ophthalmology, and rare diseases,
GLC conducts trials to ICH/GCP and ISO 9001:2015 standards.

Website: [www.greenlightclinical.com](https://www.google.com/search?q=https%3A%2F%2Fwww.greenlightclinical.com)

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Taimei Technology and GreenLight Clinical Expand Strategic Partnership at AusBiotech 2026 to Pioneer AI-Native Trial Execution Across Asia-Pacific ](http://www.prnasia.com/story/archive/5077546_AE77546_0?rand=184833)